A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CAE / catecholaminergic activity enhancer

[Related PubMed/MEDLINE]
Total Number of Papers: 9
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CAE  (>> Co-occurring Abbreviation)
Long Form:   catecholaminergic activity enhancer
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2017 A longevity study with enhancer substances (selegiline, BPAP) detected an unknown tumor-manifestation-suppressing regulation in rat brain. BPAP, DEP, PEA, TMS, VMAT2
2016 The significance of selegiline/(-)-deprenyl after 50 years in research and therapy (1965-2015). DEP, PEA
2014 Essential difference between the pharmacological spectrum of (-)-deprenyl and rasagiline. CAR, PD
2010 [The feasibility of synthetic enhancer substances for preventive nanotherapy]. ---
2001 Enantioselective synthesis and absolute configuration of (-)-1-(benzofuran-2-yl)-2-propylaminopentane, ((-)-BPAP), a highly potent and selective catecholaminergic activity enhancer. ---
1998 (-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain. ---
1996 (-)Deprenyl and (-)1-phenyl-2-propylaminopentane, [(-)PPAP], act primarily as potent stimulants of action potential-transmitter release coupling in the catecholaminergic neurons. ---
1996 High performing rats are more sensitive toward catecholaminergic activity enhancer (CAE) compounds than their low performing peers. ANOVA, CARs, EFs, IRs
1996 Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain. DMI, PEA